Blood schizontocidal activity of methylene blue in combination with antimalarials againstPlasmodium falciparum - Archive ouverte HAL Access content directly
Journal Articles Parasite Year : 2007

Blood schizontocidal activity of methylene blue in combination with antimalarials againstPlasmodium falciparum

Abstract

Methylene blue (MB) is the oldest synthetic antimalarial. It is not used anymore as antimalarial but should be reconsidered. For this purpose we have measured its impact on both chloroquine sensitive and resistant Plasmodium strains. We showed that around 5 nM of MB were able to inhibit 50% of the parasite growth in vitro and that late rings and early trophozoites were the most sensitive stages; while early rings, late trophozoites and schizonts were less sensitive. Drug interaction study following fractional inhibitory concentrations (FIC) method showed antagonism with amodiaquine, atovaquone, doxycycline, pyrimethamine; additivity with artemether, chloroquine, mefloquine, primaquine and synergy with quinine. These results confirmed the interest of MB that could be integrated in a new low cost antimalarial combination therapy.
Fichier principal
Vignette du fichier
Garavito_23176.pdf (695.41 Ko) Télécharger le fichier
Origin Files produced by the author(s)
Loading...

Dates and versions

hal-02143176 , version 1 (29-05-2019)

Identifiers

Cite

Giovanny Garavito, Stephane Bertani, Javier Rincon, Séverine Maurel, Marie-Carmen Monje, et al.. Blood schizontocidal activity of methylene blue in combination with antimalarials againstPlasmodium falciparum. Parasite, 2007, 14 (2), pp.135-140. ⟨10.1051/parasite/2007142135⟩. ⟨hal-02143176⟩
68 View
35 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More